Logo image of OKYO

OKYO PHARMA LTD (OKYO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OKYO - GG00BMFG5F62 - Common Stock

2.28 USD
+0.15 (+7.04%)
Last: 1/28/2026, 10:05:59 AM
Fundamental Rating

0

Taking everything into account, OKYO scores 0 out of 10 in our fundamental rating. OKYO was compared to 525 industry peers in the Biotechnology industry. OKYO may be in some trouble as it scores bad on both profitability and health. OKYO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year OKYO has reported negative net income.
  • OKYO had a negative operating cash flow in the past year.
  • In the past 5 years OKYO always reported negative net income.
  • In the past 5 years OKYO always reported negative operating cash flow.
OKYO Yearly Net Income VS EBIT VS OCF VS FCFOKYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -127.98%, OKYO is not doing good in the industry: 80.57% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -127.98%
ROE N/A
ROIC N/A
ROA(3y)-491.55%
ROA(5y)-329.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OKYO Yearly ROA, ROE, ROICOKYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OKYO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OKYO Yearly Profit, Operating, Gross MarginsOKYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

0

2. Health

2.1 Basic Checks

  • The number of shares outstanding for OKYO has been increased compared to 1 year ago.
  • Compared to 5 years ago, OKYO has more shares outstanding
  • There is no outstanding debt for OKYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OKYO Yearly Shares OutstandingOKYO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
OKYO Yearly Total Debt VS Total AssetsOKYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

  • OKYO has an Altman-Z score of -59.58. This is a bad value and indicates that OKYO is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -59.58, OKYO is doing worse than 91.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -59.58
ROIC/WACCN/A
WACCN/A
OKYO Yearly LT Debt VS Equity VS FCFOKYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M -6M -8M

2.3 Liquidity

  • A Current Ratio of 0.40 indicates that OKYO may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.40, OKYO is doing worse than 91.05% of the companies in the same industry.
  • A Quick Ratio of 0.40 indicates that OKYO may have some problems paying its short term obligations.
  • OKYO's Quick ratio of 0.40 is on the low side compared to the rest of the industry. OKYO is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
OKYO Yearly Current Assets VS Current LiabilitesOKYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

0

3. Growth

3.1 Past

  • OKYO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.21%, which is quite impressive.
EPS 1Y (TTM)79.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • OKYO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.47% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-25.49%
EPS Next 2Y-41.42%
EPS Next 3Y-23.47%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OKYO Yearly EPS VS EstimatesOKYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 -0.1 -0.2 -0.3 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

  • OKYO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OKYO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OKYO Price Earnings VS Forward Price EarningsOKYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OKYO Per share dataOKYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • OKYO's earnings are expected to decrease with -23.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-23.47%

0

5. Dividend

5.1 Amount

  • OKYO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

OKYO PHARMA LTD / OKYO FAQ

What is the ChartMill fundamental rating of OKYO PHARMA LTD (OKYO) stock?

ChartMill assigns a fundamental rating of 0 / 10 to OKYO.


What is the valuation status for OKYO stock?

ChartMill assigns a valuation rating of 0 / 10 to OKYO PHARMA LTD (OKYO). This can be considered as Overvalued.


Can you provide the profitability details for OKYO PHARMA LTD?

OKYO PHARMA LTD (OKYO) has a profitability rating of 0 / 10.


How financially healthy is OKYO PHARMA LTD?

The financial health rating of OKYO PHARMA LTD (OKYO) is 0 / 10.